Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukoencephalopathy, Progressive Multifocal | 14 | 2019 | 110 | 2.190 |
Why?
|
| JC Virus | 16 | 2019 | 97 | 2.170 |
Why?
|
| Sequence Deletion | 4 | 2012 | 15 | 1.050 |
Why?
|
| Capsid Proteins | 7 | 2019 | 27 | 0.900 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2014 | 80 | 0.720 |
Why?
|
| Simian virus 40 | 3 | 2013 | 10 | 0.630 |
Why?
|
| Neurons | 5 | 2019 | 332 | 0.550 |
Why?
|
| Polyomavirus Infections | 3 | 2014 | 26 | 0.490 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2013 | 15 | 0.490 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2014 | 13 | 0.450 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2013 | 4 | 0.420 |
Why?
|
| Tumor Virus Infections | 2 | 2013 | 17 | 0.400 |
Why?
|
| Genes, Viral | 3 | 2018 | 7 | 0.390 |
Why?
|
| Cerebellar Diseases | 1 | 2011 | 8 | 0.370 |
Why?
|
| Multiple Sclerosis | 4 | 2014 | 88 | 0.360 |
Why?
|
| Polyomavirus | 1 | 2011 | 5 | 0.360 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2013 | 17 | 0.330 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 144 | 0.310 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 185 | 0.300 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 8 | 0.230 |
Why?
|
| Brain | 4 | 2018 | 1604 | 0.220 |
Why?
|
| DNA, Viral | 4 | 2014 | 41 | 0.210 |
Why?
|
| HIV Infections | 3 | 2019 | 475 | 0.200 |
Why?
|
| Natalizumab | 4 | 2014 | 20 | 0.190 |
Why?
|
| Humans | 19 | 2021 | 25900 | 0.190 |
Why?
|
| Epoxide Hydrolases | 1 | 2021 | 11 | 0.190 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2021 | 4 | 0.180 |
Why?
|
| Antigens, Viral, Tumor | 3 | 2019 | 11 | 0.170 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2014 | 40 | 0.170 |
Why?
|
| Pyramidal Cells | 2 | 2012 | 35 | 0.170 |
Why?
|
| Genotype | 1 | 2021 | 335 | 0.170 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2013 | 16 | 0.160 |
Why?
|
| Animals | 5 | 2013 | 3504 | 0.160 |
Why?
|
| Base Sequence | 2 | 2012 | 106 | 0.160 |
Why?
|
| Capsid | 2 | 2014 | 13 | 0.160 |
Why?
|
| Macaca mulatta | 3 | 2013 | 60 | 0.160 |
Why?
|
| Meninges | 1 | 2019 | 6 | 0.160 |
Why?
|
| Choroid Plexus | 1 | 2019 | 5 | 0.160 |
Why?
|
| Oligodendroglia | 1 | 2019 | 34 | 0.150 |
Why?
|
| Sequence Alignment | 2 | 2011 | 20 | 0.150 |
Why?
|
| Adult | 8 | 2021 | 7517 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 41 | 0.140 |
Why?
|
| Astrocytes | 1 | 2019 | 145 | 0.140 |
Why?
|
| Fibroblasts | 2 | 2008 | 54 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2008 | 506 | 0.130 |
Why?
|
| Female | 10 | 2021 | 14543 | 0.130 |
Why?
|
| Cerebellum | 2 | 2006 | 39 | 0.120 |
Why?
|
| Virus Replication | 2 | 2013 | 51 | 0.120 |
Why?
|
| Cell Line | 2 | 2013 | 276 | 0.110 |
Why?
|
| Meningitis, Aseptic | 1 | 2014 | 4 | 0.110 |
Why?
|
| HIV Seronegativity | 1 | 2014 | 18 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2014 | 16 | 0.110 |
Why?
|
| Herpesviridae | 1 | 2014 | 2 | 0.110 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 4 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2006 | 23 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2014 | 11 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2014 | 32 | 0.110 |
Why?
|
| DNA | 1 | 2014 | 99 | 0.110 |
Why?
|
| Virus Assembly | 1 | 2013 | 3 | 0.110 |
Why?
|
| Virion | 1 | 2013 | 15 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2013 | 14 | 0.110 |
Why?
|
| Meningoencephalitis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2014 | 52 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 11 | 0.110 |
Why?
|
| Coinfection | 1 | 2013 | 20 | 0.100 |
Why?
|
| Male | 6 | 2021 | 14176 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2013 | 76 | 0.100 |
Why?
|
| Viral Core Proteins | 1 | 2012 | 2 | 0.100 |
Why?
|
| Genes, Regulator | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 4 | 0.100 |
Why?
|
| Viral Tropism | 1 | 2012 | 4 | 0.100 |
Why?
|
| Genome, Viral | 1 | 2012 | 14 | 0.100 |
Why?
|
| HIV | 2 | 2019 | 39 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 55 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 19 | 0.090 |
Why?
|
| Young Adult | 2 | 2021 | 1929 | 0.090 |
Why?
|
| Immunocompetence | 1 | 2011 | 5 | 0.090 |
Why?
|
| Mass Screening | 1 | 2011 | 168 | 0.080 |
Why?
|
| Middle Aged | 4 | 2021 | 8556 | 0.080 |
Why?
|
| Zambia | 2 | 2021 | 17 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 115 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 148 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2006 | 91 | 0.060 |
Why?
|
| Adolescent | 1 | 2011 | 2070 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 589 | 0.060 |
Why?
|
| Autopsy | 2 | 2019 | 334 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2005 | 60 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2005 | 86 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 355 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2002 | 5 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2002 | 14 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 258 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 294 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 431 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cerebellar Cortex | 1 | 2019 | 7 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 328 | 0.040 |
Why?
|
| Gene Expression | 1 | 2019 | 197 | 0.040 |
Why?
|
| Biomarkers | 1 | 2019 | 536 | 0.030 |
Why?
|
| Aged | 3 | 2014 | 8658 | 0.030 |
Why?
|
| Pancytopenia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon beta-1a | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2014 | 8 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 52 | 0.030 |
Why?
|
| Neisseria meningitidis | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Protozoan | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cryptococcus | 1 | 2014 | 3 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Toxoplasmosis | 1 | 2014 | 6 | 0.030 |
Why?
|
| Toxoplasma | 1 | 2014 | 6 | 0.030 |
Why?
|
| Cryptococcosis | 1 | 2014 | 6 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 6 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 89 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 15 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 103 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 40 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 53 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 81 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 3 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 5 | 0.030 |
Why?
|
| COS Cells | 1 | 2013 | 33 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 41 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 25 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2014 | 87 | 0.030 |
Why?
|
| Seizures | 1 | 2014 | 70 | 0.030 |
Why?
|
| Neuroglia | 1 | 2013 | 47 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 123 | 0.030 |
Why?
|
| Mutation | 1 | 2014 | 319 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 301 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 847 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1376 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1708 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2014 | 961 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2006 | 14 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2006 | 24 | 0.020 |
Why?
|
| Viral Load | 1 | 2006 | 75 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 3342 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 61 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 42 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 611 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 695 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 7 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2002 | 9 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 107 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 151 | 0.010 |
Why?
|
| Survivors | 1 | 2002 | 69 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1071 | 0.010 |
Why?
|